The new rules, which apply to transmucosal immediate-release fentanyl (TIRF) drugs, state that providers should prescribe TIRF drugs only to opioid-tolerant patients and require prescribers to document and verify the patient's opioid tolerance, in today's bite-sized hospital and health industry news from Maryland, New York, and Virginia.
Create your free account to access 1 resource, including the latest research and webinars.
You have 1 free members-only resource remaining this month.
1 free members-only resources remaining
1 free members-only resources remaining
You've reached your limit of free insights
Never miss out on the latest innovative health care content tailored to you.
You've reached your limit of free insights
You have 10 free members-only resources remaining this month.
You've reached your limit of free monthly insights